Skip to main content

Day: November 19, 2025

Toll Brothers at Veranda Bay Community Opens in Flagler Beach, Florida

New luxury home community offers modern single-family homes with resort-style amenities FLAGLER BEACH, Fla., Nov. 19, 2025 (GLOBE NEWSWIRE) — Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, today announced the grand opening of Toll Brothers at Veranda Bay, a new community of modern single-family homes in Flagler Beach, Florida. The Sales Center is now open at 172 Stillwater Drive in Flagler Beach. Toll Brothers at Veranda Bay offers new homes in a premier Flagler Beach location on the banks of the Intracoastal Waterway, just minutes from Flagler beach. This gated community offers modern single-family home designs with spacious floor plans and options for personalization at the Toll Brothers Design Studio. Homes feature 3 to 5 bedrooms, 2 to 4 baths, and 2- to 3-car garages. Homes are priced from...

Continue reading

ZIRCON-X Analysis: TLX250-CDx Impacts Clinical Decision Making for Almost Half of Patients with Indeterminate Renal Masses

MELBOURNE, Australia and INDIANAPOLIS, Nov. 20, 2025 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces results from the ZIRCON-X study which finds that almost half of all patients imaged with TLX250-CDx (Zircaix®1, 89Zr-DFO-girentuximab) PET/CT2 would have undergone a change in clinical management, when compared with baseline standard of care (SOC) imaging. The data will be presented at the 26th Annual Meeting of the Society of Urologic Oncology (SUO) being held in Phoenix, AZ, December 2 – 5, 2025. ZIRCON-X was a non-interventional, prospective, post-hoc study sponsored by Telix – using imaging data from Telix’s parent pivotal Phase 3 ZIRCON study3 – that assessed the impact of TLX250-CDx imaging on clinical decision-making versus SOC contrast-enhanced diagnostic imaging in 294 patients...

Continue reading

Rapala VMC Corporation Issues EUR 25 Million Hybrid Bond

Rapala VMC Corporation, Stock Exchange Release, November 19, 2025 at 09:15 p.m. EET NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. Rapala VMC Corporation (“Rapala VMC”) issues hybrid capital securities in the aggregate amount of EUR 25 million (the “Capital Securities”). The Capital Securities bear a fixed coupon interest of 9.000 per cent per annum until November 27, 2028 (the “Reset Date”) and, from the Reset Date, a floating interest rate as defined in the terms and conditions of the Capital Securities. The Capital Securities do not have a specified maturity date, but Rapala VMC is entitled to redeem...

Continue reading

THEON Invited by OCCAR to Sign Contract Revision

PRESS RELEASE Bloomberg (THEON:NA) / Reuters (THEON.AS)19 November 2025 – Theon Sensors SA, fully owned subsidiary of Theon International Plc (THEON) is pleased to announce that it has been officially invited by the Organisation for Joint Armament Cooperation (OCCAR), together with Hensoldt AG (HENSOLDT), to sign the first Contract Revision of its existing contract for the supply of additional advanced man-portable equipment. Pursuant to last week’s formal approval procedures by the two participating nations, Germany and Belgium, THEON and HENSOLDT will proceed with the official signing of the OCCAR Contract Revision on December 10, 2025, for the purchase of several thousand systems which are expected to materially increase THEON’s existing backlog. As per customary procedures, details of this Contract Revision will be announced...

Continue reading

TrustCo Reinforces Commitment to Shareholders with Quarterly Dividend; Highlighting Over 120 Years of Uninterrupted Payments

GLENVILLE, N.Y., Nov. 19, 2025 (GLOBE NEWSWIRE) — The Board of Directors of TrustCo Bank Corp NY (TrustCo, Nasdaq: TRST) on November 18, 2025 declared a quarterly cash dividend of $0.38 per share, or $1.52 per share on an annualized basis. The dividend will be payable on January 2, 2026 to shareholders of record at the close of business on December 5, 2025. Chairman, President, and Chief Executive Officer Robert J. McCormick said: “We are very pleased that the financial strength demonstrated by our performance so far this year continues to support the company’s 120-year commitment to returning capital to shareholders through the payment of quarterly dividends. Providing this dependable payout is fundamental to what we are as a company and is one part of our broader commitment to building and maintaining shareholder and customer...

Continue reading

Novartis announces plans to build flagship manufacturing hub in North Carolina

Expansion represents significant investment in North Carolina and is expected to create 700 new jobs in the state by end of 2030Enables manufacturing of medicines across company’s main therapeutic areas in one geographic locationMarks latest milestone in company’s previously announced $23 billion investment in US infrastructureEast Hanover, November 19, 2025 – Novartis, a leading global innovative medicines company, today announced plans to expand its operations in North Carolina, creating a new flagship manufacturing hub with end-to-end manufacturing capabilities. The strategic investment is a major step to ensure all key Novartis medicines for US patients are manufactured in the US and delivered to patients across the country at scale. This announcement is part of Novartis’ $23 billion investment in US-based infrastructure over...

Continue reading

Novartis announces plans to build flagship manufacturing hub in North Carolina

Expansion represents significant investment in North Carolina and is expected to create 700 new jobs in the state by end of 2030Enables manufacturing of medicines across company’s main therapeutic areas in one geographic locationMarks latest milestone in company’s previously announced $23 billion investment in US infrastructureBasel, November 19, 2025 – Novartis, a leading global innovative medicines company, today announced plans to expand its operations in North Carolina, creating a new flagship manufacturing hub with end-to-end manufacturing capabilities. The strategic investment is a major step to ensure all key Novartis medicines for US patients are manufactured in the US and delivered to patients across the country at scale. This announcement is part of Novartis’ $23 billion investment in US-based infrastructure over the next...

Continue reading

Canacol Energy Granted Creditor Protection to Pursue Restructuring

TORONTO, Nov. 19, 2025 (GLOBE NEWSWIRE) — Canacol Energy Ltd. (TSX: CNE) (OTCQX: CNNEF) (BVC: CNE.C) (“Canacol” or the “Company”) announces that the Company and its subsidiaries have obtained an initial order for creditor protection (the “Initial Order”) from the Court of King’s Bench of Alberta (the “Court”) pursuant to the Companies’ Creditors Arrangement Act (the “CCAA”). The order provides for a stay of proceedings for 10 days staying action by creditors and appointed KPMG Inc. as Court-appointed Monitor of the Company and its applicant subsidiaries (in such capacity, the “Monitor”). The CCAA is a Canadian federal statute that allows debtor companies to restructure their affairs under court supervision, with the aim of maximizing value for stakeholders and preserving business operations. Under the CCAA, the Company continues...

Continue reading

GlobalFoundries and BAE Systems Collaborate on Semiconductors for Space 

GF’s semiconductor technology, securely manufactured in the U.S., will be radiation-hardened by BAE Systems to withstand the harsh environment of space MALTA, N.Y., Nov. 19, 2025 (GLOBE NEWSWIRE) — GlobalFoundries (Nasdaq: GFS) (GF) today announced that BAE Systems will use GF’s advanced FinFET semiconductor technology in a new offering for space applications. Securely manufactured at GF’s facility in Malta, New York, this technology enables BAE Systems and others to create highly differentiated chips for electronic systems to withstand the harsh environment of space. With its new RH12™ Storefront, BAE Systems, using its intellectual property and design techniques, has created a turnkey solution to allow for the rapid development of custom radiation-hardened semiconductor solutions for space applications. These chips are...

Continue reading

Alpha Modus Files Patent Infringement Lawsuit Against Inditex and Zara in the Eastern District of Texas

MARSHALL, Texas, Nov. 19, 2025 (GLOBE NEWSWIRE) — Alpha Modus, Corp., a U.S.-based retail technology company and subsidiary of Alpha Modus Holdings, Inc. (NASDAQ: AMOD), today announced that it has filed a patent infringement lawsuit in the U.S. District Court for the Eastern District of Texas against Industria de Diseño Textil, S.A. (Inditex) and Zara USA, Inc. The lawsuit asserts infringement of U.S. Patent Nos. 11,042,890; 11,301,880; 12,026,731; and 12,354,121, which collectively protect Alpha Modus’s real-time retail analytics, personalized shopper engagement, inventory intelligence, and automated in-store purchase technologies. The complaint alleges that Zara’s retail environment, including its RFID garment tracking systems, digital surveillance technologies, mobile application features, and inventory replenishment platforms...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.